FDA Drugs (New Approvals & NDA)Original article
Communicating Drug Interaction and QTc Information in the U.S. Prescribing Information - 09/23/2026
RegulatoryNeutral
AI Analysis
Summary
FDA is conducting a webinar on 09/23/2026 to discuss draft and final guidance documents regarding drug interaction and QTc information in prescription drug and biological product labeling.
Importance:2/10
Sentiment:
0.00
regulatoryprescribing_informationdrug_interactionQTcguidance
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 6, 2026 5:37 PM